for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

New threat to Pfizer-Allergan deal

Posted

The U.S. Treasury Department has taken steps to curb tax-avoiding corporate "inversions." As Hayley Platt reports, the pending $160 billion merger of Pfizer and Allergan is seen as a potential casualty.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up